Previous Article | Next Article ![]()
Infection and Immunity, February 2004, p. 1159-1161, Vol. 72, No. 2
0019-9567/04/$08.00+0 DOI: 10.1128/IAI.72.2.1159-1161.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Departments of Obstetrics and Gynecology,1 Medicine and Pathobiology,2 Pathobiology, University of Washington, Seattle, Washington3
Received 8 September 2003/ Returned for modification 8 October 2003/ Accepted 24 October 2003
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
(Part of this research was presented at Chlamydia 2002, Helsinki, Finland, 20 to 23 August 2002 [A. B. Lichtenwalner, D. L. Patton, W. C. Van Voorhis, Y. T. Cosgrove Sweeney, and C.-C. Kuo, Proc. 4th Meet. Eur. Soc. Chlamydia Res., p. 197-198].)
Sexually mature female pigtailed macaques (Macaca nemestrina) were used. Animals were housed at the University of Washington National Primate Research Center. The animal use protocol for this study was approved by the Animal Care Committee at the University of Washington.
The autotransplantation of salpingeal fimbrial tissue into subcutaneous abdominal "pockets" at multiple sites has been described previously (11, 12). Two weeks after the surgery, baseline histologic data were obtained by excising transplant tissue from each animal for histologic evaluation by standard hematoxylin and eosin staining. The remaining pockets were then inoculated with 105 inclusion-forming units of C. trachomatis serovar E in 50 µl of the chlamydial transport medium SPG, a phosphate buffer containing sucrose and glutamic acid (sucrose, 75 g; KH2PO4, 0.52 g; Na2HPO4, 1.22 g; glutamic acid, 0.72 g; H2O to 1 liter [pH 7.4 to 7.6]). At 21 days postinoculation, two pockets were removed from each animal for the evaluation of baseline inflammatory reactions. One monkey was used for testing the dose response, and the remaining three monkeys were used for testing variously treated chlamydial antigens. The chlamydial antigens tested were UV-inactivated whole organisms, recombinant chlamydial HSP60 (rcHSP60), rcHSP10, major outer membrane protein (MOMP), and outer membrane complex protein (OMP). Control antigens used were recombinant glutathione S-transferase (rGST), which was used for cloning recombinant chlamydial antigens, and SPG. Fifty micrograms of antigen in 50 µl was inoculated into each pocket. Groups of two to six pockets per animal were randomly assigned to each test antigen. Pocket tissues were removed 48 h after inoculation for histologic examination. All surgical procedures were conducted while animals were under general anesthesia with ketamine and atropine.
The test antigens were prepared as follows. (i) To obtain purified chlamydial organisms, C. trachomatis serovar E (E/UW-5/Cx) elementary bodies (EBs) were grown in HeLa 229 cells and purified by density gradient centrifugation with diatrizoate meglumin (Hypaque-76; Winthrop-Breon Laboratories, New York, N.Y.) (6). (ii) To obtain inactivated organisms, chlamydial EBs were inactivated by UV irradiation (7). (iii) To obtain chlamydial outer membrane proteins, chlamydial proteins were fractionated into Sarkosyl-insoluble and -soluble fractions according to the method of Caldwell et al. (2). The Sarkosyl-insoluble fraction (MOMP) contains chlamydial outer membrane complexes, and the Sarkosyl-soluble fraction (OMP) contains the majority of the other chlamydial EB proteins, including HSP10 and HSP60. (iv) To obtain recombinant proteins, affinity-purified rcHSP60 (8) was obtained from R. Morrison and rcHSP10 was obtained from G. Bryne (8). rGST from Schistosoma japonicum was used to express rcHSP. All proteins were tested and found to be free of endotoxins (sensitivity, 0.1 endotoxin unit).
Swab samples were obtained for culture and ligase chain reaction for the detection of chlamydial infection from the removed tissues, which were subsequently placed in 10% formalin and processed for histologic examination. Fixed tissues were embedded in paraffin, thin sectioned, and stained with hematoxylin and eosin for light microscopic examination. T lymphocytes were identified by staining with a pan-T-cell stain, and polymorphonuclear leukocytes (were identified by a myeloperoxidase stain. Cells infiltrating the submucosa were counted in five randomly chosen high-power fields (x400 magnification), and the average number of cells was calculated. The observer was blind as to the tissue origins. Data were analyzed by analysis of variance (ANOVA) followed by Tukey's multiple-comparison test. P values of 0.05 or less were considered significant.
Histologic examination of uninoculated pocket tissues showed no inflammation. A mild inflammation was observed 21 days after inoculation with live chlamydial organisms and before testing for DTH reactions (11). The dose-response experiment, involving a series of rcHSP60 concentrations (0, 5, 20, and 50 µg), showed a dose-dependent lymphocytic response (Fig. 1) characteristic of DTH at 48 h (11). The maximum reaction was observed at the 50-µg concentration. Tests with various antigens showed that only rcHSP60 elicited a significant lymphocytic reaction (P < 0.05, ANOVA and Tukey's multiple-comparison test) (Fig. 2). Mild lymphocytic reactions to MOMP, OMP, and rcHSP10 were also observed. However, the differences from controls were not statistically significant (Fig. 2). No plasma cell or polymorphonuclear leukocyte cell response was observed. No inflammatory reaction was observed in the tissues tested with control antigens. The OMP fraction contains chlamydial HSP60 (cHSP60) in addition to other proteins. In this protein fraction, the concentration of cHSP60 may not be high enough to induce a significant DTH reaction. The weak response of the whole EBs, which should contain cHSP60 in the chlamydial envelope, may be due to a proportionally smaller amount of cHSP60 relative to the total amount of protein injected into the pocket.
|
|
The molecular mechanism of the DTH response to cHSP60 is of current interest. cHSP60 of C. pneumoniae has been shown to interact with Toll-like receptors, triggering innate immunity (1). Whether Toll-like receptors are involved in the immunopathogenesis of C. trachomatis genital tract infections in the pigtailed macaque has not been investigated. Such studies may further our understanding of immunopathogenesis in this model.
In conclusion, this study demonstrated that cHSP-60 does elicit DTH in the experimental salpingeal model used and supports clinical observations indicating a role for cHSP60 in the immunopathogenesis of tubal damage (4, 17). This pathogenic mechanism is similar to that involved in ocular trachoma disease in experimental monkeys (5). This hypothesis should be further tested in an animal experiment to see whether animals sensitized with cHSP60 and infected with C. trachomatis in the salpinx develop severe salpingitis and tubal damage.
| ACKNOWLEDGMENTS |
|---|
During this study, animals were housed at the University of Washington National Primate Research Center. Prior approval for the use of these animals in this protocol was obtained from the Animal Care Committee at the University of Washington.
None of the authors have commercial or other associations that might pose a conflict of interest.
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
| 1. | Bulut, Y., E. Faure, L. Thomas, H. Karahashi, K. S. Michelsen, O. Equils, S. G. Morrison, R. P. Morrison, and M. Arditi. 2002. Chlamydial heat shock protein 60 activates macrophages and endothelial cells through Toll-like receptor 4 and MD2 in a MYD88-dependent pathway. J. Immunol. 168:1435-1440. |
| 2. | Caldwell, H. D., J. Kromhout, and J. Schachter. 1981. Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect. Immun. 31:1161-1176. |
| 3. | Cohen, C. R., S. S. Sinei, E. A. Bukusi, J. J. Bwayo, K. K. Holmes, and R. C. Brunham. 2000. Human leukocyte antigen class II DQ alleles associated with Chlamydia trachomatis tubal infertility. Obstet. Gynecol. 95:72-77. |
| 4. | Eckert, L. O., S. E. Hawes, P. Wolner-Hanssen, D. M. Money, R. W. Peeling, R. C. Brunham, C. E. Stevens, D. A. Eschenbach, and W. E. Stamm. 1997. Prevalence and correlates of antibody to chlamydial heat shock protein in women attending sexually transmitted disease clinics and women with confirmed pelvic inflammatory disease. J. Infect. Dis. 175:1453-1458.[Medline] |
| 5. | Grayston, J. T., S.-P. Wang, S.-K. Yeh, and C.-C. Kuo. 1985. Importance of reinfection in the pathogenesis of trachoma. Rev. Infect. Dis. 7:717-725.[Medline] |
| 6. | Kuo, C.-C., and J. T. Grayston. 1976. Interaction of Chlamydia trachomatis organisms and HeLa 229 cells. Infect. Immun. 13:1103-1109. |
| 7. | Kuo, C.-C. 1978. Immediate cytotoxicity of Chlamydia trachomatis for mouse peritoneal macrophages. Infect. Immun. 20:613-618. |
| 8. | LaVerda, D., L. N. Albanese, P. E. Ruther, S. G. Morrison, R. P. Morrison, K. A. Ault, and G. I. Byrne. 2000. Seroreactivity to Chlamydia trachomatis Hsp10 correlates with severity of human genital tract disease. Infect. Immun. 68:303-309. |
| 9. | Lichtenwalner, A. B., D. L. Patton, Y. T. C. Sweeney, L. K. Guar, and W. E. Stamm. 1997. Evidence of genetic susceptibility to Chlamydia trachomatis-induced pelvic inflammatory disease in the pig-tailed macaque. Infect. Immun. 65:2250-2253.[Abstract] |
| 10. | Patton, D. L., C.-C. Kuo, S.-P. Wang, and S. A. Halbert. 1987. Distal tubal obstruction induced by repeated Chlamydia trachomatis salpingitis infection in pig-tailed macaques. J. Infect. Dis. 155:1292-1299.[Medline] |
| 11. | Patton, D. L., Y. T. Sweeney, and C.-C. Kuo. 1994. Demonstration of delayed hypersensitivity in Chlamydia trachomatis salpingitis in moneys: a pathogenic mechanism of tubal damage. J. Infect. Dis. 169:680-683.[Medline] |
| 12. | Patton, D. L., P. Wolner-Hanssen, and K. K. Holmes. 1990. The effect of Chlamydia trachomatis on the female reproductive tract of the Macaca nemestrina after a single tubal challenge following repeated cervical inoculation. Obstet. Gynecol. 76:643-650. |
| 13. | Peeling, R. W., J. Kimani, E. M. Plummer, I. Maclean, M. Cheang, J. Bwayo, and R. C. Brunham. 1997. Antibody to chlamydial hsp60 predicts an increased risk for chlamydial pelvic inflammatory disease. J Infect. Dis. 175:1153-1158.[Medline] |
| 14. | Peeling, R. W., D. L. Patton, Y. T. Cosgrove Sweeney, M. S. Cheang, A. B. Lichtenwalner, R. C. Brunham, and W. E. Stamm. 1999. Antibody response to the chlamydial heat-shock protein 60 in an experimental model of chronic pelvic inflammatory disease in monkeys (Macaca nemestrina). J. Infect. Dis. 180:774-779.[CrossRef][Medline] |
| 15. | Taylor, H. R., S. L. Johnson, J. Schachter, H. D. Caldwell, and R. A. Prendergast. 1987. Pathogenesis of trachoma: the stimulus for inflammation. J. Immunol. 138:3023-3027.[Abstract] |
| 16. | Van Voorhis, W. C., L. K. Barrett, Y. T. Cosgrove Sweeney, C.-C. Kuo, and D. L. Patton. 1997. Repeated Chlamydia trachomatis infection of Macaca nemestrina fallopian tubes produces a Th1-like cytokine response associated with fibrosis and scarring. J. Infect. Dis. 65:2175-2182. |
| 17. | Witkin, S. S., J. Jeremias, M. Toth, and W. J. Ledger. 1993. Cell-mediated immune response to the recombinant 57-kDa heat-shock protein of Chlamydia trachomatis in women with salpingitis. J. Infect. Dis. 167:1379-1383.[Medline] |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|